Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Regionally Stratified Psoriasis Case Identification and Misclassification Correction in National Health Insurance Claims Data in Indonesia (PESONA): Protocol for a Serial Cross-Sectional Study
ABSTRACT
Background:
Administrative claims from national health insurance programmes support population-level surveillance of chronic skin diseases. Case ascertainment for psoriasis is complicated by diagnostic complexity, uneven diagnostic capacity across facility tiers, and the resulting risk of diagnostic misclassification. Regional disparities in access to specialist care may further distort ascertainment. Within Indonesia’s tiered national health insurance programme, Jaminan Kesehatan Nasional (JKN), no standardised approach to psoriasis case ascertainment exists.
Objective:
This protocol describes the Psoriasis Epidemiology Study in Indonesia (PESONA) framework. PESONA is a replicable, step-by-step approach to psoriasis case identification, correction of diagnostic misclassification, and regional prevalence estimation in JKN administrative claims data.
Methods:
PESONA is a serial cross-sectional analytical protocol applied to annual JKN sample data from 2017 to 2024, provided by the Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan. It has six sequential steps across three data strata: confirmed cases from specialist encounters (Steps 1–2), derivation of misclassification parameters (Steps 3–4), and probable cases from lower-level encounters (Steps 5–6). Misclassification is quantified as the false discovery rate (FDR) and false omission rate (FOR) of referral entry diagnoses against specialist final diagnoses, by referral source. Each step is run separately in five regions defined by the Indonesia Case Base Groups (INA-CBGs) tariff regionalization. Regional prevalence is estimated per 100,000 JKN members using survey sampling weights. National case totals are obtained by summing weighted regional counts. National prevalence is estimated as a membership-weighted average of regional prevalences, and regional estimates are pooled by random-effects meta-analysis in the pooled-stratified specification, which carries between-region heterogeneity into the national confidence interval.
Results:
The study commenced in 15 January 2026. As of September 2026, analysis of the 2017–2024 sample data has been completed.
Conclusions:
The PESONA framework offers a transparent and replicable approach to psoriasis case identification and misclassification correction in JKN claims data. Its regional stratification accounts for unequal access to specialist care. The approach may be adaptable to other chronic skin diseases and to comparable tiered health systems.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.